Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioForce Nanosciences HoldingsBFNH +17.50%32 Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus rates BFNH with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,744 Consumer Packaged Goods companies, BioForce Nanosciences Holdings ranks worse than 57339.39% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for BioForce Nanosciences Holdings's Debt-to-Equity or its related term are showing as below:
BFNH's Debt-to-Equity is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 0.41 * Ranked among companies with meaningful Debt-to-Equity only.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
BioForce Nanosciences Holdings Debt-to-Equity Related Terms
BioForce Nanosciences Holdings Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BFNH vs BHST, LSF, HAIN: Debt-to-Equity Comparison
For the Packaged Foods subindustry, BioForce Nanosciences Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioForce Nanosciences Holdings Debt-to-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioForce Nanosciences Holdings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where BioForce Nanosciences Holdings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioForce Nanosciences Holdings (BFNH) has a Debt-to-Equity of 0.00 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BioForce Nanosciences Holdings and its competitors. According to the industry distribution chart, BioForce Nanosciences Holdings ranks #999999 out of 1744 companies in the Consumer Packaged Goods industry.
Is BioForce Nanosciences Holdings' Debt-to-Equity too high?
BioForce Nanosciences Holdings' current Debt-to-Equity is 0.00. Based on the distribution chart, BioForce Nanosciences Holdings ranks #999999 out of 1744 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, BioForce Nanosciences Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does BioForce Nanosciences Holdings' Debt-to-Equity compare to BHST and LSF?
According to the Consumer Packaged Goods industry distribution chart, BioForce Nanosciences Holdings ranks #999999 out of 1744 companies for Debt-to-Equity. This places BioForce Nanosciences Holdings in the lower half of its industry. The industry median Debt-to-Equity is 0.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Consumer Packaged Goods company?
The median Debt-to-Equity among Consumer Packaged Goods companies is 0.41, based on 1,744 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BioForce Nanosciences Holdings and its competitors. For the Consumer Packaged Goods industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioForce Nanosciences Holdings's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioForce Nanosciences Holdings stock overvalued right now?
BioForce Nanosciences Holdings (BFNH) has a current Debt-to-Equity of 0.00. The current Debt-to-Equity is 0.00. BioForce Nanosciences Holdings' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For BioForce Nanosciences Holdings (BFNH), the current Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioForce Nanosciences Holdings Business Description
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing. BioForce currently markets its products through social media and telemarketing. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, will be important channels for the Company's Eclipse product-lines.
32GF Score
Get the complete analysis for BFNH
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BFNH has been successfully added to your 
